Skip to content

CARM CARISMA THERAPEUTICS INC COM

Follow

COM (common)

7 managers (7 13F filers) reported a position in CARM shares at 2025-12-31, 1,565,031 shares in all. 2 filers opened a position and 28 filers sold out during the quarter.

Managers
7
13F filers
7
New
2
Added
1
Reduced
0
Sold out
28
Shares held by filers
1,565,031

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2025

Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Merck & Co., Inc.in group Merck & Co., Inc.1,473,240$63.3K0.02%013F-HRTimelineGroup
XTX Topco Ltdin group XTX Topco Ltd40,097$1.72K<0.01%new13F-HRTimelineGroup
Empowered Funds, LLC30,988$1.33K<0.01%013F-HR/ATimeline
Baader Bank Aktiengesellschaft19,515$517<0.01%new13F-HRTimeline
Union Bancaire Privee, UBP SA785$28<0.01%+25013F-HRTimeline
IFP Advisors, Inc206$9<0.01%013F-HRTimeline
ORG Partners LLC200$8<0.01%013F-HRTimeline